CAS: 322455-70-9

TLR2/6 agonist, may bind TLR10. Activates NF-κB, triggers IL-8, IL-1β, CCL20, TNF-α. Boosts IFNγ-induced CXCL10 in melanoma.

FSL-1 is an advanced antimicrobial agent, which is derived from fatty acids and modified through a synthesis process involving surface-active molecules. This compound exhibits enhanced antimicrobial efficacy through its unique mode of action that disrupts microbial cell membranes by integrating into the lipid bilayer, causing structural instability and leakage of cellular contents. Such action effectively eliminates a broad spectrum of bacteria and fungi. The primary applications of FSL-1 are in the fields of biotechnology and pharmaceuticals, where it is utilized for sterilizing surfaces, equipment, and sometimes incorporated into formulations as a preservative. It is also finding increasing utilization in research laboratories for the purpose of maintaining sterile environments and in the development of novel antimicrobial treatments. Its efficacy and versatility make it an invaluable tool for scientists investigating microbial resistance and those engaged in the development of next-generation antimicrobial strategies.